News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
721,017 Results
Type
Article (46811)
Company Profile (295)
Press Release (673911)
Multimedia
Podcasts (66)
Webinars (12)
Section
Business (209265)
Career Advice (2189)
Deals (36018)
Drug Delivery (114)
Drug Development (82358)
Employer Resources (191)
FDA (16359)
Job Trends (15251)
News (352645)
Policy (33253)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (10)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (10)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (8)
2024 Genetown Digital (5)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (6)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2743)
Academic (2)
Accelerated approval (5)
Adcomms (23)
Allergies (87)
Alliances (50995)
ALS (92)
Alzheimer's disease (1424)
Antibody-drug conjugate (ADC) (131)
Approvals (16358)
Artificial intelligence (275)
Autoimmune disease (22)
Automation (16)
Bankruptcy (366)
Best Places to Work (11826)
BIOSECURE Act (20)
Biosimilars (107)
Biotechnology (201)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (281)
Cancer (2284)
Cardiovascular disease (179)
Career advice (1837)
Career pathing (33)
CAR-T (160)
Cell therapy (443)
Cervical cancer (20)
Clinical research (66712)
Collaboration (861)
Compensation (525)
Complete response letters (21)
COVID-19 (2668)
CRISPR (42)
C-suite (248)
Cystic fibrosis (101)
Data (2208)
Decentralized trials (2)
Denatured (31)
Depression (43)
Diabetes (272)
Diagnostics (6520)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (47)
Drug discovery (123)
Drug pricing (107)
Drug shortages (26)
Duchenne muscular dystrophy (96)
Earnings (87456)
Editorial (39)
Employer branding (25)
Employer resources (161)
Events (115912)
Executive appointments (741)
FDA (17618)
Featured Employer (53)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (776)
Gene editing (109)
Generative AI (22)
Gene therapy (318)
GLP-1 (756)
Government (4569)
Grass and pollen (4)
Guidances (59)
Healthcare (19197)
Huntington's disease (25)
IgA nephropathy (29)
Immunology and inflammation (122)
Indications (29)
Infectious disease (2813)
Inflammatory bowel disease (141)
Inflation Reduction Act (10)
Influenza (51)
Intellectual property (98)
Interviews (345)
IPO (16717)
IRA (42)
Job creations (3842)
Job search strategy (1570)
Kidney cancer (10)
Labor market (41)
Layoffs (489)
Leadership (19)
Legal (8069)
Liver cancer (76)
Lung cancer (328)
Lymphoma (154)
Machine learning (7)
Management (62)
Manufacturing (314)
MASH (68)
Medical device (13531)
Medtech (13536)
Mergers & acquisitions (19845)
Metabolic disorders (706)
Multiple sclerosis (82)
NASH (22)
Neurodegenerative disease (93)
Neuropsychiatric disorders (27)
Neuroscience (1974)
NextGen: Class of 2025 (6717)
Non-profit (4650)
Northern California (2687)
Now hiring (40)
Obesity (381)
Opinion (223)
Ovarian cancer (77)
Pain (88)
Pancreatic cancer (84)
Parkinson's disease (152)
Partnered (21)
Patents (236)
Patient recruitment (112)
Peanut (48)
People (59297)
Pharmaceutical (71)
Pharmacy benefit managers (18)
Phase I (20780)
Phase II (29363)
Phase III (21884)
Pipeline (1191)
Policy (143)
Postmarket research (2643)
Preclinical (9066)
Press Release (72)
Prostate cancer (107)
Psychedelics (32)
Radiopharmaceuticals (252)
Rare diseases (386)
Real estate (6228)
Recruiting (72)
Regulatory (22717)
Reports (55)
Research institute (2477)
Resumes & cover letters (374)
Rett syndrome (5)
RNA editing (5)
RSV (44)
Schizophrenia (72)
Series A (137)
Series B (87)
Service/supplier (14)
Sickle cell disease (55)
Southern California (2307)
Special edition (15)
Spinal muscular atrophy (150)
Sponsored (30)
Startups (3779)
State (2)
Stomach cancer (14)
Supply chain (69)
Tariffs (39)
The Weekly (33)
United States (23404)
Vaccines (714)
Venture capitalists (43)
Weight loss (253)
Women's health (37)
Worklife (18)
Date
Today (165)
Last 7 days (857)
Last 30 days (2664)
Last 365 days (33432)
2025 (10775)
2024 (35947)
2023 (40860)
2022 (51924)
2021 (56499)
2020 (54898)
2019 (47645)
2018 (35936)
2017 (33085)
2016 (32665)
2015 (38767)
2014 (32375)
2013 (27536)
2012 (29798)
2011 (30535)
2010 (29032)
Location
Africa (793)
Alabama (54)
Alaska (7)
Arizona (240)
Arkansas (14)
Asia (39520)
Australia (6502)
California (6166)
Canada (2016)
China (528)
Colorado (273)
Connecticut (273)
Delaware (147)
Europe (85905)
Florida (911)
Georgia (214)
Hawaii (1)
Idaho (58)
Illinois (549)
India (27)
Indiana (315)
Iowa (11)
Japan (162)
Kansas (106)
Kentucky (25)
Louisiana (11)
Maine (62)
Maryland (901)
Massachusetts (4627)
Michigan (237)
Minnesota (407)
Mississippi (2)
Missouri (82)
Montana (27)
Nebraska (25)
Nevada (64)
New Hampshire (65)
New Jersey (1744)
New Mexico (30)
New York (1761)
North Carolina (1007)
North Dakota (9)
Northern California (2687)
Ohio (205)
Oklahoma (14)
Oregon (34)
Pennsylvania (1382)
Puerto Rico (12)
Rhode Island (33)
South America (1171)
South Carolina (22)
South Dakota (1)
Southern California (2307)
Tennessee (102)
Texas (917)
Utah (185)
Virginia (146)
Washington D.C. (66)
Washington State (557)
West Virginia (3)
Wisconsin (63)
721,017 Results for "urovant sciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
AccuStem Sciences, Inc. and EmeritusDX Announce Partnership to Commercialize MSC Test for Lung Cancer Screening
April 29, 2025
·
4 min read
Business
New Jersey’s Life Sciences Scene Continues Expanding Beyond Big Pharma
Known as the home of big-name companies including Johnson & Johnson, New Jersey has become a destination for more and more small and midsize life sciences businesses. Choose New Jersey, Grace Therapeutics and Onyx Equities executives discuss the state’s life sciences scene.
April 10, 2025
·
6 min read
·
Angela Gabriel
Business
Urovant Sciences® Announces Partnership with Thinx Inc. to Help Americans with Overactive Bladder This Travel Season
Urovant Sciences ® Announces Partnership with Thinx Inc. to Help Americans with Overactive Bladder This Travel Season.
November 14, 2022
·
9 min read
Press Releases
AccuStem Sciences, Inc. Announces Acquisition of Proprietary MSC Lung Cancer Screening Test
March 19, 2025
·
5 min read
Press Releases
AccuStem Sciences, Inc. Signs Agreement to Access Blood Samples from Lung Cancer Screening Trial to Expedite MSC Commercialization Plan
April 16, 2025
·
4 min read
Press Releases
CV Sciences, Inc. To Announce Year End and Fourth Quarter 2024 Results On March 27, 2025
March 20, 2025
·
3 min read
Press Releases
Britannia Life Sciences Inc. Provides Corporate Update
January 29, 2025
·
3 min read
Press Releases
Psilera Inc. & atai Life Sciences Announce Licensing Agreement for DMT Patent Portfolio
February 21, 2025
·
4 min read
Job Creations
Massachusetts Increases Life Sciences Investment by $500M Over 10 Years
Massachusetts’ increased investment in the life sciences industry includes boosting its life sciences tax incentive program by $10 million annually, aiding job creation in the state.
November 21, 2024
·
2 min read
·
Angela Gabriel
Business
Urovant Sciences® Announces Collaboration with Holly Robinson Peete to Help Raise Awareness for Overactive Bladder and Treatment Options
Urovant Sciences, Inc., and Holly Robinson Peete Collaborate to Bring Awareness to Overactive Bladder (OAB) Symptoms and Management Options as Part of the Time To Go™ Campaign.
January 19, 2023
·
8 min read
1 of 72,102
Next
